EUVIMEDEUVIMED entdecken
Crossref

The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High‐Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse

Hao Jiang, Peng Zhu, Yan Chen, Jing Xiong, Puxiang Chen, Qing Li iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Hao Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, The Second Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: DNA Methylation, Papillomavirus Infections, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation (NNSF) of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the rapid development and maturation of high‐risk human papillomavirus (hrHPV) genotyping kits, it is crucial to understand the specific patterns of methylation in different hrHPV statuses, rather than simply categorizing them as hrHPV positive or negative. To achieve this goal, we first assessed the prevalence and CIN3+ risk of specific hrHPV genotypes in 184 cervical scrapings and then evaluated the performance of five host genes methylation to distinguish CIN3+ from

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsHuman Papillomavirus VirusesPapillomaviridaeHumansFemaleAdultEarly Detection of CancerGenotypeMiddle AgedDNA, Viral

Stichwörter der Autor:innen

DNA methylationcervical cancercervical intraepithelial neoplasia grade 3 or worsehrHPV‐negativehuman papillomavirus

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China.
  • Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China.
  • National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Changsha, Hunan, China.
  • Xiangya Medical Laboratory, Central South University, Changsha, China.

ORCID-Profile: Qing Li

Förderung

  • National Natural Science Foundation (NNSF) of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Jiang, H., Zhu, P., Chen, Y., Xiong, J., Chen, P., & Li, Q. (2026). The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High‐Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse. Journal of Medical Virology. https://doi.org/10.1002/jmv.70836

Vancouver

Jiang H, Zhu P, Chen Y, Xiong J, Chen P, Li Q. The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High‐Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse. Journal of Medical Virology. 2026. doi:10.1002/jmv.70836

BibTeX
@article{Jiang2026,
  author = {Jiang, Hao and Zhu, Peng and Chen, Yan and Xiong, Jing and Chen, Puxiang and Li, Qing},
  title = {The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High‐Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70836}
}
Kostenlos starten →